1. Home
  2. NSSC vs OGN Comparison

NSSC vs OGN Comparison

Compare NSSC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$37.33

Market Cap

1.6B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.43

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
OGN
Founded
1969
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
NSSC
OGN
Price
$37.33
$13.43
Analyst Decision
Strong Buy
Hold
Analyst Count
6
5
Target Price
$48.17
$11.40
AVG Volume (30 Days)
364.5K
12.1M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
1.33%
0.60%
EPS Growth
N/A
N/A
EPS
0.70
0.55
Revenue
$181,621,000.00
$6,216,000,000.00
Revenue This Year
$13.63
$0.45
Revenue Next Year
$10.05
$1.67
P/E Ratio
$52.59
$24.43
Revenue Growth
N/A
N/A
52 Week Low
$26.44
$5.69
52 Week High
$47.61
$13.48

Technical Indicators

Market Signals
Indicator
NSSC
OGN
Relative Strength Index (RSI) 37.20 77.13
Support Level $29.88 $10.05
Resistance Level $44.43 $13.44
Average True Range (ATR) 1.48 0.07
MACD -0.38 -0.21
Stochastic Oscillator 28.28 79.07

Price Performance

Historical Comparison
NSSC
OGN

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: